We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$32.4B
1-Year Est. Return
58.5%
This Fund
S&P 500
This Quarter
Est. Return
+23.19%
1 Year Est. Return
+58.5%
3 Year Est. Return
+155.34%
5 Year Est. Return
+222.91%
10 Year Est. Return
–
AUM
$32.4B
AUM Growth
+$5.91B
(+22%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
17.19%
Holding
1,187
New
164
Increased
545
Reduced
215
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$261M |
| 2 |
Microchip Technology
MCHP
|
+$204M |
| 3 |
Lumentum
LITE
|
+$184M |
| 4 |
Philip Morris
PM
|
+$154M |
| 5 |
Chubb
CB
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$215M |
| 2 |
Applied Materials
AMAT
|
+$165M |
| 3 |
Datadog
DDOG
|
+$121M |
| 4 |
Seagate
STX
|
+$117M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.1% |
| 2 | Technology | 24.74% |
| 3 | Financials | 10.96% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Global X Copper Miners ETF NEW
COPX
$8.04B
| $27.3M | 0.08% |
+355,224
| New | +$29.6M |
|
302
Ascendis Pharma A/S
ASND
$17.2B
| $27.3M | 0.08% |
102,469
| – | – |
|
303
Spyre Therapeutics
SYRE
$7.82B
| $27.2M | 0.08% |
306,049
+40,157
| +15% | +$2.93M |
|
|
ORKA
304
Oruka Therapeutics
ORKA
$6.06B
| $27.1M | 0.08% |
285,247
-289,635
| -50% | -$19.3M |
|
305
Capital One
COF
$127B
| $27M | 0.08% |
134,449
+11,596
| +9% | +$2.22M |
|
306
S&P Global
SPGI
$121B
| $27M | 0.08% |
66,174
+6,084
| +10% | +$2.57M |
|
307
Element Solutions
ESI
$8.36B
| $26.8M | 0.08% |
+561,546
| New | +$23.3M |
|
308
Linde
LIN
$214B
| $26.6M | 0.08% |
51,340
-173,636
| -77% | -$87.9M |
|
309
Exelixis
EXEL
$14B
| $26.4M | 0.08% |
485,408
| – | – |
|
310
Altria Group
MO
$115B
| $26.2M | 0.08% |
364,557
+35,759
| +11% | +$2.5M |
|
311
Savara
SVRA
$1.09B
| $26.1M | 0.08% |
4,245,119
| – | – |
|
312
Celldex Therapeutics
CLDX
$2.95B
| $26.1M | 0.08% |
700,830
+200,703
| +40% | +$6.48M |
|
313
Nurix Therapeutics
NRIX
$2.66B
| $25.8M | 0.08% |
1,064,006
+138,562
| +15% | +$2.36M |
|
314
Mid-America Apartment Communities
MAA
$14.5B
| $25.8M | 0.08% |
185,362
+180,795
| +3,959% | +$23.6M |
|
315
Wingstop
WING
$3.18B
| $25.5M | 0.08% |
+147,285
| New | +$23.2M |
|
316
NewAmsterdam Pharma
NAMS
$2.57B
| $25.5M | 0.08% |
752,489
+181
| +0% | +$5.96K |
|
317
Procore
PCOR
$8.11B
| $25.1M | 0.08% |
+618,065
| New | +$30.6M |
|
318
Caesars Entertainment
CZR
$6.05B
| $25.1M | 0.08% |
+831,866
| New | +$23.4M |
|
319
Moelis & Co
MC
$4.75B
| $25.1M | 0.08% |
383,317
+240,775
| +169% | +$15.8M |
|
320
Apple Hospitality REIT
APLE
$3.72B
| $24.5M | 0.08% |
+1,459,400
| New | +$20.9M |
|
321
McDonald's
MCD
$179B
| $24.5M | 0.08% |
90,528
-65,470
| -42% | -$18.8M |
|
322
General Dynamics
GD
$95.5B
| $24.3M | 0.08% |
68,630
-43,293
| -39% | -$14.8M |
|
323
Biogen
BIIB
$31.9B
| $24.3M | 0.08% |
112,463
+3,431
| +3% | +$656K |
|
324
Lemonade
LMND
$3.84B
| $24.2M | 0.07% |
371,755
+192,147
| +107% | +$11.2M |
|
|
BLD
325
DELISTED
TopBuild
BLD
| $24.1M | 0.07% |
68,000
+10,558
| +18% | +$4.35M |
|
Similar funds
PAM
FDCDDQ
SUT
Woodline Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Woodline Partners held 1,187 positions worth $32.4B, up 22% from $26.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $1.91B of net new capital in Q2 2026, opening 164 new positions and adding to 545 existing holdings. Its largest new stake was SpaceX: 508,235 shares worth $86.8M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Texas Instruments, an estimated $215M trimmed.
- Woodline Partners's largest Q2 2026 buy was SpaceX: 508,235 shares worth $86.8M.
- Woodline Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $261M increase.
- Woodline Partners's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $215M.
- Woodline Partners fully exited SSR Mining in Q2 2026, selling an estimated $103M.
- Woodline Partners's ten largest holdings make up 17% of its $32.4B portfolio in Q2 2026.
- Woodline Partners opened 164 new positions and closed 176 in Q2 2026.
- Woodline Partners's portfolio value rose 22% quarter-over-quarter to $32.4B.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.